Taxus Pharmaceuticals Holdings Inc. (TXSP) Financial Statements (2024 and earlier)

Company Profile

Business Address 245-16 HORACE HARDING EXPRESSWAY,
LITTLE NECK, NY 11362
State of Incorp. NY
Fiscal Year End June 30
Industry (SIC) 5912 - Drug Stores and Proprietary Stores (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2018
MRQ
6/30/2017
6/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 614
Cash and cash equivalents 614
Inventory, net of allowances, customer advances and progress billings  39
Inventory  39
Total current assets: 652
Noncurrent Assets
Property, plant and equipment  5
Other undisclosed noncurrent assets 35
Total noncurrent assets: 310
TOTAL ASSETS: 963
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 6341
Accrued liabilities 6341
Total current liabilities: 6341
Noncurrent Liabilities
Total liabilities: 6341
Equity
Equity, attributable to parent (54)22
Common stock 11
Additional paid in capital 649340
Accumulated deficit (703)(319)
Total equity: (54)22
TOTAL LIABILITIES AND EQUITY: 963

Income Statement (P&L) ($ in thousands)

3/31/2018
TTM
6/30/2017
6/30/2015
Revenues 6101
Cost of revenue (25)(72)
Gross profit: (19)29
Operating expenses (98)(256)
Operating loss: (117)(227)
Loss from continuing operations before income taxes: (117)(227)
Income tax benefit  88
Loss from continuing operations: (117)(138)
Loss before gain (loss) on sale of properties: (117)(138)
Net loss: (117)(138)
Other undisclosed net loss attributable to parent  (88)
Net loss available to common stockholders, diluted: (117)(227)

Comprehensive Income ($ in thousands)

3/31/2018
TTM
6/30/2017
6/30/2015
Net loss: (117)(138)
Comprehensive loss, net of tax, attributable to parent: (117)(138)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: